A ketogenic diet successfully controlled seizures in a 7-year-old with a rare NALCN genetic mutation, but caused dangerous fat buildup in the blood within weeks. Switching to a modified diet using medium-chain triglycerides instead of standard fats reversed the fat problem while maintaining seizure control, showing that personalized dietary adjustments and careful monitoring are essential for safe ketogenic diet use in this genetic condition.
A 7-year-old boy with a rare genetic form of epilepsy started a ketogenic diet to control his seizures. The diet worked amazingly well—his seizures dropped dramatically and he developed better. However, within weeks, his body accumulated dangerously high levels of fat in his blood (triglycerides). When doctors switched him to a modified ketogenic diet using different types of fats, the problem reversed. This case shows that while ketogenic diets can help rare genetic epilepsy, doctors need to carefully monitor blood fat levels and may need to adjust the type of fats used.
Key Statistics
A 2026 case report documented a 7-year-old boy with a NALCN mutation whose triglyceride levels reached 1,580 mg/dL (more than 10 times normal) within weeks of starting a standard ketogenic diet formula, but returned to normal after switching to medium-chain triglycerides.
In this case report, a ketogenic diet produced marked seizure reduction and developmental improvement in a child with NALCN-related epilepsy, demonstrating that this rare genetic condition may respond to ketogenic therapy despite previous lack of safety data.
A 2026 case report showed that formula-induced hypertriglyceridemia from a ketogenic diet was reversible through dietary modification, with seizure control maintained after switching from long-chain saturated fats to medium-chain triglycerides or monounsaturated fats.
The Quick Take
- What they studied: Whether a ketogenic diet (high-fat, low-carb eating plan) could safely treat seizures in a child with a rare genetic mutation affecting nerve cell function
- Who participated: One 7-year-old boy with a newly discovered genetic mutation (NALCN) causing severe seizures and developmental delays that didn’t respond to regular seizure medications
- Key finding: The ketogenic diet reduced seizures dramatically and improved the child’s development, but caused dangerous fat buildup in the blood (triglycerides reached 1,580 mg/dL, more than 7 times normal) within weeks. Switching to a modified diet with different types of fats reversed this problem.
- What it means for you: If you or a child has this rare genetic epilepsy, a ketogenic diet may help control seizures, but doctors must monitor blood fat levels closely and may need to use special fat sources. This is not a reason to avoid the diet, but rather to use it carefully with medical supervision.
The Research Details
This is a case report, which means doctors documented the medical story of one patient in detail. The 7-year-old boy had a rare genetic mutation that caused his brain cells to misfire, leading to frequent seizures. Genetic testing identified a new type of mutation in the NALCN gene—a gene that controls how nerve cells communicate. Because his seizures didn’t respond to standard medications, doctors decided to try a ketogenic diet, which is a well-established treatment for hard-to-control epilepsy.
The doctors started him on a classic ketogenic diet using a special high-fat formula designed for children. They carefully tracked his seizure activity, development, and blood work over time. Within weeks, they noticed something unexpected: his blood triglycerides (a type of fat) skyrocketed to dangerous levels. This forced them to modify his diet by changing the types of fats he consumed, switching to medium-chain triglycerides (MCTs) and monounsaturated fats instead of the standard long-chain saturated fats.
By documenting this case in detail, the doctors could show other physicians what to watch for when treating similar patients. Case reports are valuable because they describe unusual situations that might not show up in larger studies, helping doctors learn from real-world experience.
This research matters because NALCN mutations are extremely rare, and doctors have very little information about how to safely treat them. By publishing this detailed case, the doctors provide a roadmap for other physicians who might encounter similar patients. It shows that ketogenic diets can work for this genetic condition, but also reveals an important safety concern that requires monitoring and dietary adjustment.
As a case report, this study describes one patient’s experience in detail rather than comparing many patients. This means we can’t draw broad conclusions that apply to everyone with this mutation. However, case reports are valuable for identifying unexpected side effects and treatment strategies. The strength of this report is that the doctors documented everything carefully, including genetic testing, seizure counts, and blood work. The main limitation is that one patient’s experience may not represent what happens in other patients with the same mutation.
What the Results Show
The ketogenic diet produced remarkable results for seizure control. The boy’s seizure frequency dropped significantly, and his overall development improved noticeably. Parents and doctors observed better alertness, more engagement, and improved developmental milestones. These positive changes appeared within the first weeks of starting the diet.
However, blood tests revealed a serious metabolic problem. The boy’s triglyceride levels climbed to 1,580 mg/dL—more than seven times the normal range (which is typically under 150 mg/dL). This dangerous fat buildup in the blood is called hypertriglyceridemia and can increase the risk of heart and pancreas problems if left untreated.
When the doctors modified the diet to use medium-chain triglycerides (MCTs) and monounsaturated fats instead of standard long-chain saturated fats, the triglyceride levels returned to normal. Importantly, the seizure control remained excellent even with the dietary changes. This showed that the benefit for seizures didn’t depend on using the standard high-fat formula—alternative fat sources worked just as well for seizure control while protecting the child’s metabolic health.
The case demonstrates that this particular genetic mutation (NALCN) responds to ketogenic diet therapy, which was previously unknown. The reversibility of the fat buildup is important—it shows this wasn’t a permanent metabolic damage but rather a response to the specific type of fat in the formula. The child’s developmental improvements alongside seizure reduction suggest the diet may have broader benefits beyond just stopping seizures.
According to Gram Research analysis, ketogenic diets are well-established for treating drug-resistant epilepsy in general, but almost nothing was known about their safety in NALCN-related epilepsy specifically. This case adds to the very limited literature on genetic channelopathies (conditions affecting how nerve cells communicate) and ketogenic diet use. The finding that fat type matters aligns with emerging research suggesting that not all ketogenic diets are identical in their metabolic effects—the source of fats appears to influence outcomes.
This is a single case report, so we cannot know if other children with NALCN mutations would experience the same fat buildup or respond the same way to dietary modification. The boy’s age, genetics, and overall health may have influenced his response. We don’t know if the fat buildup would have eventually resolved on its own or if it required dietary change. Additionally, long-term follow-up data beyond the initial treatment period isn’t described, so we can’t confirm whether the benefits lasted over months or years.
The Bottom Line
For children with NALCN-related epilepsy: Ketogenic diet therapy appears promising for seizure control (high confidence based on this case), but requires careful medical supervision including regular blood fat monitoring. If triglyceride levels rise, switching to medium-chain triglycerides or monounsaturated fats may resolve the problem while maintaining seizure control (moderate confidence—based on one case). Any child starting a ketogenic diet should have baseline blood work and regular follow-up testing.
This finding is most relevant to: (1) Children with NALCN mutations and drug-resistant epilepsy, (2) Neurologists treating rare genetic epilepsies, (3) Families considering ketogenic diet therapy for seizure disorders, (4) Dietitians designing ketogenic formulas for children. This is NOT a reason for people without NALCN mutations to avoid ketogenic diets, as the fat buildup may be specific to this genetic condition.
Seizure improvement appeared within weeks. The dangerous fat buildup also developed within weeks. Improvement in fat levels occurred after dietary modification, though the exact timeline isn’t specified in the case report. Long-term monitoring should continue indefinitely while on the diet.
Frequently Asked Questions
Can a ketogenic diet help with rare genetic seizures caused by NALCN mutations?
Yes, according to this case report, a ketogenic diet significantly reduced seizures in a child with NALCN-related epilepsy and improved developmental status. However, this is based on one patient, so more research is needed to confirm effectiveness across different individuals.
What should I watch for if my child starts a ketogenic diet for seizures?
Request baseline blood work and regular monitoring of triglyceride levels (blood fats). If levels become dangerously high, ask your doctor about switching to medium-chain triglycerides or monounsaturated fat sources instead of standard long-chain saturated fats.
Is the fat buildup from a ketogenic diet permanent?
Not necessarily. This case showed that dangerous triglyceride levels reversed when the diet was modified to use different fat sources. The key is catching the problem through regular blood work and adjusting the diet accordingly with medical guidance.
Do all children on ketogenic diets develop high triglycerides?
No. High triglycerides may be more common in children with certain genetic conditions like NALCN mutations. Regular monitoring helps identify the problem early if it develops, allowing doctors to make dietary adjustments before complications occur.
Can you stay on a ketogenic diet if your triglycerides get too high?
Yes, this case shows you can continue the diet by modifying the fat sources. Switching from standard long-chain saturated fats to medium-chain triglycerides or monounsaturated fats maintained seizure control while normalizing blood fat levels.
Want to Apply This Research?
- Track weekly seizure counts and monthly blood triglyceride levels if on a ketogenic diet. Set reminders for scheduled blood work and record the specific type of fats consumed (standard formula vs. MCT-based vs. monounsaturated fat sources).
- If using a ketogenic diet for seizure control, work with your doctor to identify which fat sources work best for your body. The app can help you log which formula or fat type you’re using and correlate it with seizure frequency and any available blood work results.
- Create a dashboard showing: (1) Seizure frequency trend over time, (2) Scheduled blood work dates and results, (3) Current diet formula/fat source, (4) Any symptoms of metabolic problems (unusual fatigue, stomach pain, etc.). Share this data with your healthcare team at each visit.
This case report describes one child’s experience with a ketogenic diet and a rare genetic condition. It is not medical advice and should not replace consultation with a qualified neurologist or pediatrician. Ketogenic diets carry metabolic risks that require medical supervision, including regular blood work monitoring. Anyone considering a ketogenic diet for seizure management should work with a healthcare team experienced in both epilepsy treatment and ketogenic diet management. The findings from a single case cannot be generalized to all patients with NALCN mutations or other genetic conditions. Always consult with your doctor before starting, modifying, or stopping any seizure treatment.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.